ANI Interest Expense vs Accounts Payable Analysis

ANIP Stock  USD 69.13  0.56  0.80%   
ANI Pharmaceuticals financial indicator trend analysis is way more than just evaluating ANI Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ANI Pharmaceuticals is a good investment. Please check the relationship between ANI Pharmaceuticals Interest Expense and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

Interest Expense vs Accounts Payable

Interest Expense vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ANI Pharmaceuticals Interest Expense account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between ANI Pharmaceuticals' Interest Expense and Accounts Payable is 0.89. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of ANI Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of ANI Pharmaceuticals' Interest Expense and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of ANI Pharmaceuticals are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Interest Expense i.e., ANI Pharmaceuticals' Interest Expense and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.89
Relationship DirectionPositive 
Relationship StrengthStrong

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Accounts Payable

An accounting item on the balance sheet that represents ANI Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of ANI Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from ANI Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ANI Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.As of 03/28/2024, Selling General Administrative is likely to grow to about 157.9 M, while Discontinued Operations is likely to drop slightly above 156 K.
 2021 2022 2023 2024 (projected)
Gross Profit115.5M177.6M245.5M257.8M
Total Revenue216.1M316.4M486.8M511.2M

ANI Pharmaceuticals fundamental ratios Correlations

0.950.841.00.90.70.160.940.60.950.6-0.480.930.531.00.960.95-0.480.980.97-0.190.090.680.920.970.09
0.950.870.950.880.610.060.970.580.870.58-0.380.840.610.940.950.93-0.380.940.89-0.24-0.090.680.850.960.14
0.840.870.830.860.650.160.810.430.820.43-0.370.770.480.850.850.77-0.370.790.82-0.06-0.170.680.650.83-0.09
1.00.950.830.880.640.150.940.660.920.66-0.480.930.560.980.950.96-0.480.990.96-0.150.120.720.920.950.15
0.90.880.860.880.830.260.830.320.950.32-0.480.790.430.920.940.76-0.480.850.91-0.26-0.220.440.810.9-0.09
0.70.610.650.640.830.320.56-0.130.88-0.13-0.460.610.160.740.740.44-0.460.620.74-0.26-0.110.170.660.75-0.46
0.160.060.160.150.260.32-0.06-0.040.27-0.04-0.890.3-0.010.170.080.04-0.890.180.260.40.330.160.020.05-0.18
0.940.970.810.940.830.56-0.060.620.830.62-0.310.80.650.930.960.94-0.310.930.89-0.38-0.120.650.890.960.22
0.60.580.430.660.32-0.13-0.040.620.341.0-0.190.630.460.550.470.81-0.190.650.520.10.350.750.520.470.61
0.950.870.820.920.950.880.270.830.340.34-0.520.860.390.960.930.79-0.520.90.95-0.190.030.520.870.93-0.16
0.60.580.430.660.32-0.13-0.040.621.00.34-0.190.630.460.550.470.81-0.190.650.520.10.350.750.520.470.61
-0.48-0.38-0.37-0.48-0.48-0.46-0.89-0.31-0.19-0.52-0.19-0.57-0.33-0.48-0.41-0.391.0-0.53-0.58-0.21-0.33-0.41-0.39-0.40.01
0.930.840.770.930.790.610.30.80.630.860.63-0.570.460.910.820.89-0.570.930.920.090.350.730.840.840.11
0.530.610.480.560.430.16-0.010.650.460.390.46-0.330.460.50.560.6-0.330.620.61-0.38-0.160.670.590.550.14
1.00.940.850.980.920.740.170.930.550.960.55-0.480.910.50.970.92-0.480.970.97-0.220.060.640.920.970.05
0.960.950.850.950.940.740.080.960.470.930.47-0.410.820.560.970.89-0.410.940.94-0.34-0.160.550.910.980.08
0.950.930.770.960.760.440.040.940.810.790.81-0.390.890.60.920.89-0.390.960.89-0.170.140.770.870.90.34
-0.48-0.38-0.37-0.48-0.48-0.46-0.89-0.31-0.19-0.52-0.191.0-0.57-0.33-0.48-0.41-0.39-0.53-0.58-0.21-0.33-0.41-0.39-0.40.01
0.980.940.790.990.850.620.180.930.650.90.65-0.530.930.620.970.940.96-0.530.97-0.170.140.730.930.950.18
0.970.890.820.960.910.740.260.890.520.950.52-0.580.920.610.970.940.89-0.580.97-0.20.090.670.920.940.01
-0.19-0.24-0.06-0.15-0.26-0.260.4-0.380.1-0.190.1-0.210.09-0.38-0.22-0.34-0.17-0.21-0.17-0.20.570.11-0.38-0.350.12
0.09-0.09-0.170.12-0.22-0.110.33-0.120.350.030.35-0.330.35-0.160.06-0.160.14-0.330.140.090.570.350.07-0.070.08
0.680.680.680.720.440.170.160.650.750.520.75-0.410.730.670.640.550.77-0.410.730.670.110.350.550.590.09
0.920.850.650.920.810.660.020.890.520.870.52-0.390.840.590.920.910.87-0.390.930.92-0.380.070.550.920.1
0.970.960.830.950.90.750.050.960.470.930.47-0.40.840.550.970.980.9-0.40.950.94-0.35-0.070.590.920.06
0.090.14-0.090.15-0.09-0.46-0.180.220.61-0.160.610.010.110.140.050.080.340.010.180.010.120.080.090.10.06
Click cells to compare fundamentals

ANI Pharmaceuticals Account Relationship Matchups

ANI Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets456.8M461.2M771.6M760.1M904.4M949.6M
Other Current Liab36.7M54.0M63.6M69.3M99.8M104.8M
Total Current Liabilities61.7M78.6M87.5M99.4M145.5M152.8M
Total Stockholder Equity212.8M195.7M358.7M338.5M432.7M454.4M
Property Plant And Equipment Net40.6M41.3M52.7M43.2M44.6M46.8M
Net Debt123.4M177.8M187.1M238.3M94.2M98.9M
Retained Earnings17.6M(5.0M)(47.8M)(97.3M)(80.1M)(84.1M)
Accounts Payable14.6M11.3M23.0M29.3M36.7M38.5M
Cash62.3M7.9M100.3M48.2M221.1M232.2M
Non Current Assets Total269.1M290.9M449.8M415.8M384.8M404.0M
Cash And Short Term Investments62.3M7.9M100.3M48.2M221.1M232.2M
Common Stock Shares Outstanding12.0M12.0M12.6M16.3M18.2M19.1M
Liabilities And Stockholders Equity456.8M461.2M771.6M760.1M904.4M949.6M
Other Current Assets5.1M5.9M11.3M8.4M25.2M26.5M
Total Liab244.0M265.5M412.9M421.5M471.7M495.3M
Property Plant And Equipment Gross40.6M41.3M75.6M76.0M77.5M81.4M
Total Current Assets187.7M170.3M321.8M344.3M519.6M545.6M
Other Stockholder Equity200.1M212.1M384.7M398.8M479.2M503.1M
Accumulated Other Comprehensive Income(4.9M)(11.4M)(3.1M)12.2M8.9M9.3M
Short Long Term Debt Total185.7M185.7M287.4M286.5M315.3M331.1M
Short Term Debt115.7M9.9M13.2M850K977.5K928.6K
Current Deferred Revenue451K80K87K8.2M9.4M9.9M
Non Currrent Assets Other1.2M802K2.2M2.6M12.3M12.9M
Non Current Liabilities Total182.3M186.9M325.3M322.1M326.2M342.5M
Net Receivables72.1M95.8M128.5M165.4M162.1M170.2M
Net Tangible Assets28.8M3.6M36.7M58.7M52.8M55.5M
Other Assets44.6M57.5M75.1M92.7M106.6M112.0M
Long Term Debt175.8M172.4M286.5M285.7M284.8M149.2M
Retained Earnings Total Equity17.6M(5.0M)(47.8M)(97.3M)(111.9M)(117.5M)
Inventory48.2M60.8M81.7M105.4M111.2M116.8M
Deferred Long Term Liab1.5M800K500K600K690K458.1K
Intangible Assets180.4M188.5M294.1M251.6M209.0M156.5M
Property Plant Equipment40.6M41.3M52.7M43.2M49.7M52.2M
Capital Surpluse200.8M214.4M387.8M403.9M464.5M237.5M
Other Liab7K201K31.0M35.1M40.3M42.3M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ANI Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ANI Pharmaceuticals' short interest history, or implied volatility extrapolated from ANI Pharmaceuticals options trading.

Pair Trading with ANI Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ANI Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with ANI Stock

  0.7MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.79EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against ANI Stock

  0.94KA Kineta Inc Report 29th of March 2024 PairCorr
  0.77MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.73MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.72MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.71MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ANI Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ANI Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ANI Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether ANI Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ANI Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ani Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Ani Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for ANI Stock analysis

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is ANI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.89)
Earnings Share
0.85
Revenue Per Share
27.044
Quarterly Revenue Growth
0.397
Return On Assets
0.0372
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.